The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts

While drugs and related products have profoundly changed the lives of people around the world, ongoing challenges remain, including inappropriate use of a drug product. Inappropriate uses can be explained in part by ambiguous or incomplete information, for example, missing reasons for treatments, am...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jean-François Ethier, François Goyer, Paul Fabry, Adrien Barton
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/778fbcb3e5d4410c8592f13a3b61123f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:778fbcb3e5d4410c8592f13a3b61123f
record_format dspace
spelling oai:doaj.org-article:778fbcb3e5d4410c8592f13a3b61123f2021-11-25T17:50:24ZThe Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts10.3390/ijerph1822120251660-46011661-7827https://doaj.org/article/778fbcb3e5d4410c8592f13a3b61123f2021-11-01T00:00:00Zhttps://www.mdpi.com/1660-4601/18/22/12025https://doaj.org/toc/1661-7827https://doaj.org/toc/1660-4601While drugs and related products have profoundly changed the lives of people around the world, ongoing challenges remain, including inappropriate use of a drug product. Inappropriate uses can be explained in part by ambiguous or incomplete information, for example, missing reasons for treatments, ambiguous information on how to take a medication, or lack of information on medication-related events outside the health care system. In order to fully assess the situation, data from multiple systems (electronic medical records, pharmacy and radiology information systems, laboratory management systems, etc.) from multiple organizations (outpatient clinics, hospitals, long-term care facilities, laboratories, pharmacies, registries, governments) on a large geographical scale is needed. Formal knowledge models like ontologies can help address such an information integration challenge. Existing approaches like the Observational Medical Outcomes Partnership are discussed and contrasted with the use of ontologies and systems using them for data integration. The PRescription Drug Ontology 2.0 (PDRO 2.0) is then presented and entities that are paramount in addressing this problematic are described. Finally, the benefits of using PDRO are discussed through a series of exemplar situation.Jean-François EthierFrançois GoyerPaul FabryAdrien BartonMDPI AGarticledrug ontologydrug prescriptionoptimization of prescriptionmedication managementontology developmentdata annotationMedicineRENInternational Journal of Environmental Research and Public Health, Vol 18, Iss 12025, p 12025 (2021)
institution DOAJ
collection DOAJ
language EN
topic drug ontology
drug prescription
optimization of prescription
medication management
ontology development
data annotation
Medicine
R
spellingShingle drug ontology
drug prescription
optimization of prescription
medication management
ontology development
data annotation
Medicine
R
Jean-François Ethier
François Goyer
Paul Fabry
Adrien Barton
The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts
description While drugs and related products have profoundly changed the lives of people around the world, ongoing challenges remain, including inappropriate use of a drug product. Inappropriate uses can be explained in part by ambiguous or incomplete information, for example, missing reasons for treatments, ambiguous information on how to take a medication, or lack of information on medication-related events outside the health care system. In order to fully assess the situation, data from multiple systems (electronic medical records, pharmacy and radiology information systems, laboratory management systems, etc.) from multiple organizations (outpatient clinics, hospitals, long-term care facilities, laboratories, pharmacies, registries, governments) on a large geographical scale is needed. Formal knowledge models like ontologies can help address such an information integration challenge. Existing approaches like the Observational Medical Outcomes Partnership are discussed and contrasted with the use of ontologies and systems using them for data integration. The PRescription Drug Ontology 2.0 (PDRO 2.0) is then presented and entities that are paramount in addressing this problematic are described. Finally, the benefits of using PDRO are discussed through a series of exemplar situation.
format article
author Jean-François Ethier
François Goyer
Paul Fabry
Adrien Barton
author_facet Jean-François Ethier
François Goyer
Paul Fabry
Adrien Barton
author_sort Jean-François Ethier
title The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts
title_short The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts
title_full The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts
title_fullStr The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts
title_full_unstemmed The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts
title_sort prescription of drug ontology 2.0 (pdro): more than the sum of its parts
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/778fbcb3e5d4410c8592f13a3b61123f
work_keys_str_mv AT jeanfrancoisethier theprescriptionofdrugontology20pdromorethanthesumofitsparts
AT francoisgoyer theprescriptionofdrugontology20pdromorethanthesumofitsparts
AT paulfabry theprescriptionofdrugontology20pdromorethanthesumofitsparts
AT adrienbarton theprescriptionofdrugontology20pdromorethanthesumofitsparts
AT jeanfrancoisethier prescriptionofdrugontology20pdromorethanthesumofitsparts
AT francoisgoyer prescriptionofdrugontology20pdromorethanthesumofitsparts
AT paulfabry prescriptionofdrugontology20pdromorethanthesumofitsparts
AT adrienbarton prescriptionofdrugontology20pdromorethanthesumofitsparts
_version_ 1718411928529797120